Adrian Gólcz

Adrian Gólcz

Auto-generated profile, based on publicly available information

Adrian Gólcz

Medical University of Białystok

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MBMichał Bursztyn
Michał Bursztyn
MSMikołaj Szaryński
Mikołaj Szaryński
ASAdam Sikorski
Adam Sikorski
KKKarolina Kadłubowska
Karolina Kadłubowska
PJPaulina Jakubowska
Paulina Jakubowska
JGJulia Gólcz
Julia Gólcz
Menisci play a crucial biomechanical, stabilizing, sensory, and nutritional role in the knee joint, and their limited vascularization influences healing potential and treatment strategies. Meniscal tears are common, especially alongside anterior cruciate ligament (ACL) injuries, with characteristic tear types including bucket-handle, radial, flap, longitudinal, and horizontal lesions differing in frequency, treatment difficulty, and prognosis. Elite athletes are particularly vulnerable to meniscal injuries due to high mechanical loads, pivoting movements, contact mechanisms, and sport-specific demands; the risk further increases with concomitant ACL rupture and delayed reconstruction. Diagnosis requires a combination of clinical assessment and imaging, with MRI remaining the gold standard, and arthroscopy indicated in complex or uncertain cases. Treatment prioritizes meniscal preservation through repair whenever possible, as it offers better long-term joint protection despite longer rehabilitation compared to partial meniscectomy. Rehabilitation in elite athletes follows phased protocols emphasizing early protection, progressive loading, neuromuscular training, and functional testing to guide return-to-sport decisions. Preventive strategies focus on proprioceptive training and load management. Overall, optimal outcomes in athletes depend on accurate injury characterization, tissue-preserving treatment, and individualized rehabilitation aimed at restoring full function and minimizing long-term joint degeneration.

26 December 2025 in Quality in Sport
Verified
Journal Article
Open access
ASAdam Sikorski
Adam Sikorski
KKKarolina Kadłubowska
Karolina Kadłubowska
JGJulia Gólcz
Julia Gólcz
NCNatalia Chojnowska
Natalia Chojnowska
MSMikołaj Szaryński
Mikołaj Szaryński
AGAdrian Gólcz
Adrian Gólcz
Sport is commonly associated with a healthy lifestyle, improved fitness, and enhanced mental well-being. Many studies confirm that regular physical activity reduces the risk of various cancers, such as colorectal, breast, and endometrial cancer. However, specific behaviors linked to competitive or aesthetic sports, including chronic exposure to ultraviolet (UV) radiation, use of anabolic-androgenic steroids (AAS), selective androgen receptor modulators (SARMs), or muscle-building supplements (MBS), may paradoxically increase the risk of malignancies in certain organs. This review aims to synthesize current knowledge on cancers occurring more frequently or with particular relevance in athletes, with focus on diagnostic challenges and public health implications. Literature highlights several cancer types potentially more prevalent or with distinct characteristics in active individuals. These include skin cancers (especially melanoma and non-melanoma), testicular cancer (germ cell tumors), hepatocellular carcinoma (HCC), and rare sarcomas (soft tissue and bone), particularly among athletes using performance-enhancing substances. Cancer symptoms in athletes are often misinterpreted as sports injuries, which may delay diagnosis and worsen prognosis. Still, epidemiological data confirm the protective effect of moderate exercise on overall cancer incidence and mortality. Despite sport’s general oncological benefits, certain athlete groups are at increased cancer risk due to environmental or pharmacological exposures. Clinicians should maintain diagnostic vigilance in young, active patients with persistent, unexplained symptoms, and pursue prompt imaging and histopathology when needed.

18 January 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JGJulia Gólcz
Julia Gólcz
MBMichał Bursztyn
Michał Bursztyn
MSMikołaj Szaryński
Mikołaj Szaryński
ASAdam Sikorski
Adam Sikorski
KKKarolina Kadłubowska
Karolina Kadłubowska
TBTomasz Bursztyn
Tomasz Bursztyn
Myocarditis is an inflammatory disease of the myocardium that can lead to ventricular dysfunction, arrhythmias, and sudden cardiac death, particularly in athletes. The 2025 ESC Guidelines emphasize that premature return to intense exercise increases the risk of persistent inflammation, inflammatory cardiomyopathy, and malignant arrhythmias. This review summarizes current evidence and recommendations on diagnosis, rehabilitation, and return-to-sport decisions after myocarditis, focusing on athletes and the 2025 ESC guidelines. A narrative review of major guidelines and recent studies on biomarkers, imaging, athlete-specific risk, COVID-19–related myocarditis, and rehabilitation strategies was performed, selecting evidence relevant to risk stratification and safe exercise resumption. Diagnosis combines clinical findings with biomarkers (troponins, CRP, BNP/NT-proBNP). Echocardiography assesses ventricular function, while CMR remains the gold standard for tissue characterization and fibrosis detection (LGE). Rehabilitation should begin after symptom stabilization, biomarker normalization, and ventricular recovery, progressing gradually under supervision. Return to sport requires complete symptom resolution, normal function and biomarkers, and absence of significant arrhythmias. Repeat CMR is recommended if previous imaging showed edema or fibrosis. Athletes with extensive LGE or persistent dysfunction should avoid moderate-to-high-intensity activity due to high arrhythmic risk. Post-myocarditis management, especially in athletes, demands comprehensive evaluation, structured rehabilitation, and strict return-to-play criteria. The 2025 ESC guidelines stress individualized decisions based on biomarkers, ECG/Holter, and CMR to ensure safety.

7 December 2025 in Quality in Sport
Verified
Journal Article
Open access
KKKarolina Kadłubowska
Karolina Kadłubowska
ASAdam Sikorski
Adam Sikorski
MSMikołaj Szaryński
Mikołaj Szaryński
PJPaulina Jakubowska
Paulina Jakubowska
NCNatalia Chojnowska
Natalia Chojnowska
JGJulia Gólcz
Julia Gólcz
Patellofemoral Pain Syndrome (PFPS), widely known as runner’s knee, is one of the most common yet frequently misunderstood causes of anterior knee pain in active individuals. This review highlights the multifactorial nature of PFPS, emphasizing the complex interplay between biomechanical dysfunction, muscular imbalances, anatomical variations, overuse, and psychological influences. The article synthesizes current evidence on pathophysiology, clinical presentation, risk factors, and diagnostic challenges, demonstrating why accurate identification of PFPS remains difficult and often requires a comprehensive, cluster-based clinical approach. Special attention is given to the role of hip and quadriceps weakness, abnormal lower-limb alignment, and altered movement patterns in generating patellofemoral overload. The review also evaluates contemporary treatment strategies, with strong support for conservative, exercise-based rehabilitation focused on strengthening, movement retraining, flexibility, and patient education. Adjunctive tools such as taping, bracing, and orthoses are discussed as supportive options rather than primary interventions. Early, individualized therapy is essential for preventing chronic symptoms and enabling a safe, lasting return to physical activity.

2 January 2026 in Quality in Sport
Verified
Journal Article
Open access
PJPaulina Jakubowska
Paulina Jakubowska
MSMikołaj Szaryński
Mikołaj Szaryński
MJMartyna Jakubowska
Martyna Jakubowska
JGJulia Gólcz
Julia Gólcz
ASAdam Sikorski
Adam Sikorski
TBTomasz Bursztyn
Tomasz Bursztyn
This work is a literature review examining the effects of dietary protein intake on muscle strength, body composition, metabolic health, hormonal regulation, and gastrointestinal function in healthy adults, including athletes. The review covers studies on moderate and high protein intake from various sources and considers differences related to age, training level, and macronutrient balance. Research shows that higher protein intake supports increases in lean body mass and lower-body strength, especially in resistance-trained and older adults consuming at least 1.6 g/kg/day. During caloric restriction, increased protein intake helps preserve muscle mass in overweight and obese individuals. Very high protein intake above 3.4 g/kg/day may reduce testosterone levels in men, whereas moderate intakes do not produce hormonal disturbances. Protein source influences metabolic outcomes: animal and seafood protein intake is linked to a higher risk of hyperuricemia, while plant proteins, particularly soy, show protective effects. The impact of protein intake on gut function depends on carbohydrate availability, with high-protein, low-carbohydrate diets increasing constipation risk. Studies also show wide variability in dietary protein intake among athletes, emphasizing the need for individualized nutrition strategies. Overall, the review concludes that optimal protein intake depends on training type, age, diet composition, and protein quality. High-protein diets generally support muscle health and metabolic function, but the long-term consequences of very high protein intake require further study.

3 January 2026 in Quality in Sport
Verified
Journal Article
Open access
MJMartyna Jakubowska
Martyna Jakubowska
PJPaulina Jakubowska
Paulina Jakubowska
MSMikołaj Szaryński
Mikołaj Szaryński
JGJulia Gólcz
Julia Gólcz
ASAdam Sikorski
Adam Sikorski
MBMichał Bursztyn
Michał Bursztyn
Hypertrophic cardiomyopathy (HCM) in athletes is a complex condition requiring individualized risk assessment and interdisciplinary management. Advances in diagnostics, including advanced cardiac imaging and multiparametric risk stratification, allow differentiation between pathological hypertrophy and physiological adaptations in athletes. Current guidelines support carefully supervised participation in moderate and, in selected cases, high-intensity physical activity for low-risk patients. Targeted therapy, particularly the myosin inhibitor mavacamten, improves left ventricular outflow gradients, exercise tolerance, and quality of life, especially when combined with personalized training programs. Chronic use of anabolic-androgenic steroids can induce HCM-like cardiomyopathy, promote fibrosis, impair diastolic function, and increase arrhythmic risk, highlighting the need for thorough history-taking and advanced imaging. Comorbidities such as hypertension, obesity, and coronary artery disease exacerbate remodeling and arrhythmic risk, while complications like atrial fibrillation, HFpEF, and sudden cardiac death remain critical considerations. An integrated approach combining diagnostics, therapy, exercise guidance, and management of comorbidities allows safer and more flexible physical activity for athletes with HCM.